Kedar S. Prabhavalkar
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Liver X receptor: a potential target in the treatment of atherosclerosis.
Journal: Expert opinion on therapeutic targets
Published: August 25, 2022
Elabela Peptide: An Emerging Target in Therapeutics.
Journal: Current drug targets
Published: February 02, 2022
Crosstalk between NLRP3 inflammasome and calpain in Alzheimer's disease.
Journal: The European journal of neuroscience
Published: January 30, 2022
Emerging targets signaling for inflammation in Parkinson's disease drug discovery.
Journal: Metabolic brain disease
Published: January 17, 2022
Copper-lowering agents as an adjuvant in chemotherapy.
Journal: Indian journal of pharmacology
Published: June 25, 2021
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
Journal: Expert review of anti-infective therapy
Published: April 09, 2021
Combination therapy with neuropeptides for the treatment of anxiety disorder.
Journal: Neuropeptides
Published: August 18, 2020
Combating colorectal cancer with immunotherapy: Where are we?
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: August 29, 2019
Neutrophilic Asthma and Potentially Related Target Therapies.
Journal: Current drug targets
Published: June 23, 2019
Colon cancer stem cells: Potential target for the treatment of colorectal cancer.
Journal: Cancer biology & therapy
Published: May 04, 2019
SERCA stimulation: A potential approach in therapeutics.
Journal: Chemical biology & drug design
Published: April 15, 2019
High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
Journal: Current drug targets
Published: March 09, 2019
Last Updated: 09/26/2026